Investigational young Fresh Frozen Plasma (yFFP®) Treatments Study YP042022 IRCM-2022-333

As published in Frontiers in Pharmacology, the biopharmaceutical drug development firm's sponsored research has identified and validated cannabinoid ratio-controlled, Minimum Essential Mixtures (MEM) for the treatment of Parkinson's disease symptoms

According to Chris Powell of Consumer Safety Watch, the vote was 84-14 Thursday to pass the Honoring Our PACT Act, H.R. 3967 (117), requiring broadened Department of Veterans Affairs coverage for toxic exposure related to burn pits and contaminated water

The appointment is set to increase area resources and further elevate awareness of the disease, which has impacted the Pinegar family

Early data show neuroplasticity could help treat Parkinson's Disease symptoms

ElderHealth is a geriatric medical practice and virtual doctors office now accepting new patients in the Tucson, Marana, and Oro Valley areas.

Dr. Angelo Antonini, Dr. Matteo Bologna, Roy Jones, Dr. Fidias Leon-Sarmiento, and Dr. Fabrizio Stocchi, will help guide company as they advance central nervous system research

This marks the 11th U.S. provisional patent application filed by GBS covering the use of CCCM™ for unique medical disorders, creating an IP portfolio that contains formulas for up to 50 potential therapeutic indications.

Mr. Riley to Lead Corporate Development Efforts as Company Targets New Clinical Applications for its Proprietary, FDA-Cleared Blink Reflex Technology

This is the first time a Cannabinoid-Containing Complex Mixture (CCCM™) has been awarded a U.S. patent, which thereby validates GB Sciences' drug discovery platform and strengthens its intellectual property patent portfolio

GBS Global Biopharma, Inc., the Canadian holding of GB Sciences, signed an Amendment to their Agreement with the National Research Council of Canada (NRC) to include valuable testing of Mechanism of Action for its Parkinson's Disease (PD) Formulations to strengthen their Investigational New Drug (IND) Application to the US FDA in preparation for human trials addressing a $52 billion market in the US alone.

SEP361-203 study evaluating an investigational medication in people with Parkinson's disease experiencing hallucinations and delusions

SEP361-203 study evaluating an investigational medication in people with Parkinson's disease experiencing Hallucinations and Delusions

Business Booming at Parkinson's fitness-focused 413 Fitness

Rave reviews from participants and coaches for program which stresses strength, balance and confidence

Pamela Quinn choreographed an emotional performance of 50 people with Parkinson's from all over the world at the World Parkinson's Congress

Scientists shed light on cells' most fundamental process

Study aims to identify novel blood-based inflammatory markers that can be used to both identify and stratify Parkinson's disease patients

Jan-Eric Ahlfors, CEO of Fortuna Fix Inc., to present at IABS/CIRM 4th Cell Therapy Conference on June 6, 2018 in Los Angeles

Studer was selected for his groundbreaking research in stem cell-based therapies for Parkinson's disease

Furthers development of LBT-3627 focusing on immunomodulatory therapeutic strategy to treat Parkinson's disease

Four Neurology Experts Join Advisory Board Following Recent Breakthrough Discoveries Regarding Posiphen Mechanism of Action

Recently, in two research papers published in the journal Cell and Neuron, scientists at the Gladstone institutes found special neural circuits controlling walking through the study. At the same time, they also found that the circuit input was interrupted in Parkinson's disease patients.

Brain Tune Up! is a program designed to help those with neurological conditions take back their health.

A Canadian based non-profit organization, World Parkinson's Program, held a seminar in Delhi, India to lecture about Parkinson's disease. The lectures included multiple topics, and included a question and answer period. Those who attended included physicians, neurologists and other healthcare professionals from India.

World Parkinson's Program announces the continuation of its' "Fall Prevention Campaign" by delivering educational material to Africa Parkinson's Association. The material will aid those who suffer from Parkinson's disease and would not be able to afford healthcare supplies otherwise.

Allows immune system to repair brain damage; results reported in Journal of Neuroscience

Dr. Carrolee Barlow was the featured speaker at a presentation held in Rancho Santa Fe, California, to discuss developments in cause, care and cure of Parkinson's disease.